
COVID-19 - May 25, 2021
Vaxzevria authorized for emergency use in Japan
AstraZeneca’s COVID-19 vaccine has been granted a special approval for emergency use in Japan for active immunization of individuals aged 18 years and older, to prevent COVID-19 caused by SARS-CoV-2. The Japanese Ministry of Health, Labour and Welfare granted the approval based on positive Phase III efficacy and safety data from the Oxford University-led clinical […]

COVID-19 - April 8, 2021
Possible link between AstraZeneca’s vaccine and rare blood clots, states EMA
The European Medicines Agency’s safety committee (PRAC) has concluded that unusual blood clots with low blood platelets should be listed as very rare side effects of Vaxzevria (formerly COVID-19 Vaccine AstraZeneca). In reaching its conclusion, the committee took into consideration all currently available evidence, including the advice from an ad hoc expert group, it states […]